Long-term follow-up of patients with Graves' orbitopathy treated by plasmapheresis and immunosuppression.
Zielinski
C C
CC
Department for Nuclear Medicine, Ludwig Boltzmann Institute for Nuclear Medicine, University Eye Clinic II, Vienna, Austria.
Weissel
M
M
Müller
C
C
Till
P
P
Höfer
R
R
D001379:Azathioprine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006111:Graves Disease / Q000628:therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D018828:Immunoglobulins, Thyroid-Stimulating; D007165:Immunosuppression Therapy; D008775:Methylprednisolone / Q000627:therapeutic use; D008861:Microsomes / Q000276:immunology; D008875:Middle Aged; D010956:Plasmapheresis; D011379:Prognosis; D013954:Thyroglobulin / Q000276:immunology; D014787:Vision Tests
D007074:Immunoglobulin G; D018828:Immunoglobulins, Thyroid-Stimulating; D013954:Thyroglobulin; D001379:Azathioprine; D008775:Methylprednisolone